JACQUELINE DORSCH: Open Payments
NPI 1497532881 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,748 in 74 payments from 15 companies in 2025. Trend: 2023 $386 · 2024 $1,880 · 2025 $1,748
Food & beverage: $1,664Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $591 |
| Janssen Biotech, Inc. | 5 | $295 |
| Ardelyx, Inc. | 7 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $146 |
| GENZYME CORPORATION | 4 | $107 |
| Aimmune Therapeutics, Inc. | 5 | $76 |
| Madrigal Pharmaceuticals | 2 | $74 |
| PFIZER INC. | 4 | $73 |
| Novo Nordisk Inc | 3 | $61 |
| Biocon Biologics Inc | 2 | $46 |
Products named: TREMFYA, SKYRIZI, RINVOQ, IBSRELA, ENTYVIO, LINZESS, DUPIXENT, CREON.
Industry payments across FL — which companies pay providers there.
